Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2024 is 49.59% vs 14.89% in Dec 2023
Consolidate Net Profit
YoY Growth in quarter ended Dec 2024 is -18.60% vs 0.86% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2024 is 42.62% vs 27.91% in Dec 2023
Interest
YoY Growth in quarter ended Dec 2024 is 215.51% vs 504.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023
Compare Quarterly Results Of ERIS Lifescience With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2024 is -1.85% vs 2.98% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 49.59% vs 14.89% in Dec 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2024 is -8.69% vs 10.11% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -18.60% vs 0.86% in Dec 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2024 is -5.37% vs 5.81% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 42.62% vs 27.91% in Dec 2023
Quarterly - Interest
QoQ Growth in quarter ended Dec 2024 is -3.87% vs -1.49% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 215.51% vs 504.00% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024
YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023